insights_auto
Mengapa TNDM naik 14,62%?
Pelajari Lebih Lanjutchevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
US$20,07
arrow_upward
+14,62%(+2,56) 1 HR
US$20,10
arrow_upward
+0,15% (+0,030)bedtimeSetelah jam perdagangan normal
Tutup: 13 Nov, 16.00.01 GMT-5 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk TNDM...
Pembukaan
US$19,00
Tinggi
US$20,26
Rendah
US$17,48
Kapitalisasi pasar
1,40 M
Volume rata-rata
2,47 jt
Volume
4,40 jt
Harga tinggi dalam 52 minggu terakhir
US$29,65
Harga rendah dalam 52 minggu terakhir
US$12,26
EPS
-US$0,72
Beta
1,59
Saham beredar
69,79 jt
Jumlah karyawan
2 rb
Pembukaan
US$19,00
Tinggi
US$20,26
Rendah
US$17,48
Kapitalisasi pasar
1,40 M
Volume rata-rata
2,47 jt
Volume
4,40 jt
Harga tinggi dalam 52 minggu terakhir
US$29,65
Harga rendah dalam 52 minggu terakhir
US$12,26
EPS
-US$0,72
Beta
1,59
Saham beredar
69,79 jt
Jumlah karyawan
2 rb
Artikel berita
Dari sumber web dan partner berita
marketscreener.com
·
1 jam yang lalu
Tandem Diabetes Care Shares Rise After Obtaining US FDA Clearance for Tubeless Automated Insulin Delivery System
GuruFocus
·
2 jam yang lalu
Tandem Diabetes Care (TNDM) Shares Surge 13% After FDA Approval of New Tubeless Mobi Insulin Pump
kalkine.ca
·
2 jam yang lalu
Why Has Tandem Diabetes Care (NASDAQ:TNDM) Gained 11.19% Eight Days Following Its Q3 Results?
Benzinga
·
3 jam yang lalu
Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options
Profil
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Tentang Tandem Diabetes Care Inc
CEOJohn Sheridan
Karyawan2,5 rb
DidirikanJan 2006
Kantor Pusat-
SektorHealth Care
Industri-
Situstandemdiabetes.com